Medicare Enrolled
Dr. Besma Samdani, MD
Gastroenterology · Phoenixville, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Samdani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Samdani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Samdani
Dr. Besma Samdani is a gastroenterology specialist in Phoenixville, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Samdani performed 2,057 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Samdani received a total of $5,024 from 44 pharmaceutical and/or device companies across 305 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Samdani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 6% volume in PA
$5,024 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,057
Medicare services
Top 6% in PA for gastroenterology
Not available
Unique patients (not deduplicated)
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,210 | $26 | $115 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
157 | $39 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
105 | $68 | $185 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
86 | $51 | $109 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
77 | $145 | $875 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
71 | $95 | $270 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
51 | $99 | $645 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
40 | $89 | $270 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
39 | $174 | $750 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
32 | $215 | $1,025 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $136 | $410 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $45 | $120 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
26 | $41 | $85 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
22 | $68 | $154 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
20 | $109 | $301 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
20 | $23 | $101 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
19 | $184 | $750 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $107 | $240 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
11 | $87 | $530 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
59.8% high complexity
10.5% medium
29.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,024
Total received (2018-2024)
Avg $718/year across 7 years
Top 32% in PA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
305
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,068
2023
$1,155
2022
$605
2021
$248
2020
$125
2019
$355
2018
$468
Payments by company (2024)
ABBVIE INC.
$648
Janssen Biotech, Inc.
$372
Regeneron Healthcare Solutions, Inc.
$114
Phathom Pharmaceuticals, Inc.
$106
Ardelyx, Inc.
$104
Celgene Corporation
$85
Takeda Pharmaceuticals U.S.A., Inc.
$78
PFIZER INC.
$65
Merck Sharp & Dohme LLC
$63
Ipsen Biopharmaceuticals, Inc
$58
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$56
Celltrion USA Inc.
$52
Madrigal Pharmaceuticals
$47
Lilly USA, LLC
$46
IRONWOOD PHARMACEUTICALS, INC
$45
Laborie Medical Technologies Corp.
$38
AIMMUNE THERAPEUTICS, INC.
$32
GENZYME CORPORATION
$26
Boston Scientific Corporation
$18
Gilead Sciences, Inc.
$14
Top 3 companies account for 54.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$806
Janssen Biotech, Inc.
$679
AbbVie Inc.
$303
AbbVie, Inc.
$298
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$278
Regeneron Healthcare Solutions, Inc.
$240
Celgene Corporation
$232
Takeda Pharmaceuticals U.S.A., Inc.
$227
Braintree Laboratories, Inc.
$174
PFIZER INC.
$146
Ardelyx, Inc.
$143
Merck Sharp & Dohme LLC
$135
QOL Medical, LLC
$119
Ironwood Pharmaceuticals, Inc
$112
Phathom Pharmaceuticals, Inc.
$106
Gilead Sciences, Inc.
$70
UCB, Inc.
$67
NESTLE HEALTHCARE NUTRITION INC.
$64
IRONWOOD PHARMACEUTICALS, INC
$59
Ipsen Biopharmaceuticals, Inc
$58
Celltrion USA Inc.
$52
Ferring Pharmaceuticals Inc.
$49
Madrigal Pharmaceuticals
$47
Lilly USA, LLC
$46
Medtronic, Inc.
$41
Laborie Medical Technologies Corp.
$38
Nestle HealthCare Nutrition Inc.
$34
Shionogi Inc
$34
BioFire Diagnostics, LLC
$33
AIMMUNE THERAPEUTICS, INC.
$32
Intercept Pharmaceuticals, Inc.
$32
Synergy Pharmaceuticals Inc
$31
Allergan Inc.
$30
GENZYME CORPORATION
$26
W. L. Gore & Associates, Inc.
$23
INTERCEPT PHARMACEUTICALS, INC.
$23
E.R. Squibb & Sons, L.L.C.
$23
Daiichi Sankyo Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Boston Scientific Corporation
$18
Endo Pharmaceuticals Inc.
$17
RedHill Biopharma Inc.
$14
Otsuka America Pharmaceutical, Inc.
$14
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 35.6% of all-time payments
Associated products mentioned in payments ›
Aemcolo · Amitiza · BREATHTEK · BioFire FilmArray · CLENPIQ · CREON · CYLTEZO · Cimzia · Compliance EndoKit · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EOHILIA · Entyvio · GATTEX · GI Genius · GORE CARDIOFORM Septal Occluder · HUMIRA · Humira · IBSRELA · INFLECTRA · INJECTAFER · IQIRVO · LINZESS · Linzess · MAVYRET · MOTOFEN · Mavyret · Mulpleta · NASCOBAL · OCALIVA · OMVOH · REBYOTA · RELISTOR ORAL · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · Trulance · VEGZELMA · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
334
County median income
$123,041
Nearest hospital to ZIP centroid (approximate)
PHOENIXVILLE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Samdani is a clinical cardiology specialist, with above-average Medicare volume (top 6% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Samdani experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Samdani performed 1,210 infliximab infusion (remicade) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Samdani receive payments from pharmaceutical companies?
Yes. Dr. Samdani received a total of $5,024 from 44 companies across 305 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Samdani's costs compare to other gastroenterologists in Phoenixville?
Dr. Samdani's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Samdani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Phoenixville
Browse gastroenterologists in Phoenixville ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in PA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in PA
Which PA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology